As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »
Operation Warp Speed is living up to its name as, according to the project, one of the leading candidates for the COVID-19 vaccine, AstraZeneca, is partnering with life science services company IQVIA to boost its work on the shot. Under the plan, the financial details of which were not disclosed, …
Read More »
Text size And so it begins. The Nasdaq Composite has been going up for so long now, it’s hard to remember if it feels like it’s going down. Now we know. Yes, that’s an exaggeration, but not much. He had been active for seven of the past nine trading days …
Read More »
German vaccine maker CureVac has lost some shine in the race for a COVID-19 vaccine after other mRNA-based applicants have caught the attention of regulators. Still, CureVac is reported to have caught a great partner to help build its game-changing RNA “printers” that could turn global interest in its favor. …
Read More »
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »